Tradestie Institutional Equity Comparison Engine

CON vs PACS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CON Overall Edge

CON Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Concentra Group Holdings Parent, Inc. (CON) driven by superior Growth & Margin, Options & Structure while PACS counters with relative strength in Valuation, Momentum & Technical. Fundamentally, CON trades at 22.0x Forward P/E with 17.2% operating margin (+8.6% YoY revenue) versus PACS at 15.3x Forward P/E and 7.4% operating margin (+11.5% YoY). In options structure, CON sits in BREAKOUT (95th %ile IV; Dealer Gamma Walls on Pro) against PACS sits in CONSOLIDATION (11th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner PACS
CON 22.0x vs PACS 15.3x Fwd P/E
Growth & Margin Winner CON
Op Margin 17.2% vs 7.4% ยท YoY +8.6% vs +11.5%
Momentum & Technical Winner PACS
1Y +117.6% vs +159.5% ยท 52W Pos 91% vs 79%
Options & Structure Winner CON
BREAKOUT (95th %ile IV) vs CONSOLIDATION (11th %ile IV)
CON NYSE
Concentra Group Holdings Parent, Inc.
Services-Specialty Outpatient Facilities, Nec
$41.84
+0.94% 1D
Market Cap $5.2B
1M Return +4.68%
1Y Return +117.58%
Forward P/E 22.0x
Unified AI Score
43.5 / 100 HOLD
Tech 31.0 Fund 47.0 Flow 69.0 Mom 41.1
PACS NYSE
PACS Group, Inc.
Services-Skilled Nursing Care Facilities
$43.67
+1.49% 1D
Market Cap $6.8B
1M Return -8.06%
1Y Return +159.48%
Forward P/E 15.3x
Unified AI Score
46.8 / 100 HOLD
Tech 35.0 Fund 48.0 Flow 62.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CON +117.58% PACS +159.48% Spread: +41.9 pp (PACS Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CON Revenue PACS Revenue CON Op. Margin PACS Op. Margin Margin Edge
FY2022 $1.72B $2.40B 15.0% 9.6% CON
FY2023 $1.84B $3.11B 15.6% 6.7% CON
FY2024 $1.90B $4.09B 16.0% 3.0% CON
FY2025 $2.16B $5.29B 15.4% 5.9% CON

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CON (6) vs PACS (4)
Institutional Metric CON PACS Criterion Row Winner
Market Capitalization Scale $5.2B $6.8B Larger Scale PACS
Trailing P/E Ratio Valuation 24.5x 26.2x Lower Multiple CON
Forward P/E Ratio Valuation 22.0x 15.3x Lower Multiple PACS
Revenue Growth (YoY) Growth +8.6% +11.5% Higher Growth PACS
Operating Margin (TTM) Profitability 17.2% 7.4% Higher Margin CON
Net Profit Margin Profitability 9.3% 4.9% Higher Margin CON
Return on Equity (ROE) Capital Efficiency 47.2% 26.5% Higher ROE CON
52-Week Range Position Momentum 91% ($19โ€“$44) 79% ($14โ€“$52) Stronger Trend CON
Beta / 30D Volatility Risk Regime 0.52ฮฒ ยท 38% Vol 0.78ฮฒ ยท 51% Vol Lower Realized Risk CON
Unified Institutional Score Composite Signal 43.5 / 100 (HOLD) 46.8 / 100 (HOLD) Higher Composite PACS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CON vs PACS Buy Guide
CON BREAKOUT
99d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 95th %ile
IV Regime Extreme (>80th %ile)
Live CON Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PACS CONSOLIDATION
83d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 11th %ile
IV Regime Compressed (<25th %ile)
Live PACS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CON nor PACS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.